You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Extending Shelf Life of Strawberries, Spinach, Kale and Lettuce via Non-Equilibrium Short-Pulsed Plasma Activated Water Fog
SBC: AA PLASMA LLC Topic: DLA182002Current methods for food transportation and storage are insufficient in eliminating contamination threats from food-borne pathogens, resulting in frequent cases of foodborne illness or costly recalls. Perishable products within the DLAs subsistence supply chain are no exception to this problem. AAPlasma LLC proposes a non-equilibrium (cold) plasma-based solution that will continuously disinfect co ...
SBIR Phase I 2018 Department of DefenseDefense Logistics Agency -
NON-INVASIVE NEUROENHANCEMENT TO OPTIMIZE AUTONOMIC NERVOUS SYSTEM REGULATION AND BEHAVIORAL HEALTH WITH TRANSCUTANEOUS VIBRATORY STIMULATION
SBC: Apollo Neuroscience, Inc. Topic: SOCOM182002Apollo is a patent-pending AI software platform that integrates with connected hardware to deliver physiologically-reactive vibration, demonstrated in a double-blind randomizedplacebo-controlled clinical trial, to improve resilience, as measured by heart rate variability, and performance under stress by up to 25%.Using physiological measurement and environmental data, Apollo identifies each users ...
SBIR Phase I 2018 Department of DefenseSpecial Operations Command -
Plasma-Enhancement of Absorbers for Improved Removal of PFOS and PFOA from Water
SBC: AA PLASMA LLC Topic: 17NCER1ANew regulations and advisory levels for perfluoroalkyl substances have resulted in increased drinking water treatment costs or abandonment of drinking water sources. Treatment technologies are needed that can achieve low parts-per-trillion levels. Presently, there are insufficient treatment technologies that can destructively remove perfluorooctanoic acid (PFOA) and/or perfluorooctane sulfonic aci ...
SBIR Phase I 2018 Environmental Protection Agency -
Synthetic Universal Flu Vaccine
SBC: TRIA BIOSCIENCE CORP. Topic: NCIRDAbstract Type A and B Influenza viruses cause severe seasonal epidemics and less frequent but more deadly pandemic infectionsVaccination provides the best protectionalthough serious problems are confronting the global Influenza marketVirus diversity and mutation rates necessitate the annual production of hundreds of millions of vaccines using antiquated egg based technologiesCompounding this is th ...
SBIR Phase I 2018 Department of Health and Human ServicesCenters for Disease Control and Prevention -
Engineering Nanoparticle Alum Adjuvants for Pandemic Influenza Vaccines
SBC: HDT BIO CORP Topic: NCIRDProject Summary SignificanceSinceavian influenza AH Nhas sickened overpeople with amortality rateHalf of all cases occurred inwhich also saw the emergence of a highly pathogenic strainThusH Navian influenza is poised to emerge as a devastating pandemic in a worldwide population that has no pre existing immunityCurrent Hvaccineswhether attenuatedinactivatedsplit or recombinantare insufficiently imm ...
SBIR Phase I 2018 Department of Health and Human ServicesCenters for Disease Control and Prevention -
OnTRACK: Mobile Application for Pediatric Post-TBI Patient Management
SBC: CREARE LLC Topic: NCIPCPROJECT SUMMARYCreare and its clinical and research partners propose to develop a software platformOnTRACKOnline Treatment Recovery Assistance for Concussion in Kidsfor children and adolescents recovering from concussion or mild traumatic brain injurymTBIThe platform includes a mobile applicationappfor the patients and their care teamparentsteacherscoachesetca database serverand a decision support ...
SBIR Phase I 2018 Department of Health and Human ServicesCenters for Disease Control and Prevention -
Generation of Tissue Engineered Nerve Grafts from GalSafe Porcine Neurons
SBC: Axonova Medical LLC Topic: NINDSABSTRACT Peripheral nerve injuryPNIis a common consequence of trauma or surgeryand the extent of functional recovery is often unsatisfactoryMoreovera particular challenge is the repair ofmajorPNIdefined as injuries where a large segment of a nerve is losti eandgtcmor more proximal injuriese gbrachial plexus or upper armthat necessitate extremely long distances for axonal regeneration to distal end ...
SBIR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health -
A Rapid Multiplexed Assay for the Diagnosis of Viral Hepatitis at the Point of Care
SBC: INSTADIAGNOSTICS INC Topic: NCHHSTPAbstract InstadiagnosticsIDIis developing a point of carePOCdiagnostic technology platform with the goal of providing early detectionscreeningand treatment monitoring for patients at primary care centerscommunity clinicsurgent care centersand emergency departmentsThe device consists of a portable readerthe InstaReaderand disposable cartridgesInstaCartridgeA range of disease specific cartridges wil ...
SBIR Phase I 2018 Department of Health and Human ServicesCenters for Disease Control and Prevention -
Linkage-specific ubiquitylation patterns as highly sensitive markers for neurodegenerative disease
SBC: LIFESENSORS, INC. Topic: NIAWhile sensitive imaging tools to detectamyloid and tau proteins and other biomarkers for established Alzheimer s diseaseADand other neurodegenerative diseases are availablesimilar tools for detecting presymptomaticetiologic biomarkers of these diseases are notAmong the earliest steps in AD is a failure of the ubiquitin proteasome pathway to respond to misfolded proteins by causing their degradatio ...
SBIR Phase II 2018 Department of Health and Human ServicesNational Institutes of Health -
Mechanism of action of oligomer-displacing Alzheimer investigation drug, CT1812:Receptor interactions and signaling pathways
SBC: COGNITION THERAPEUTICS, INC. Topic: NIAAbstract Aoligomers are considered the most toxic structural form of Amyloid betacausing synaptotoxic changes underlying cognitive decline in Alzheimer s diseaseCogRx has developed the world s first highly brain penetrant drug that selectively displaces oligomers from synaptic receptor sites and clears oligomers from the brain into the cerebrospinal fluidCSFThis first in class drugCTallosterically ...
SBIR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health